Clinical Trial Update: BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases [Phase 2]

View source ↗

Summary

A Phase 2 study of BIO-11006 for metastatic osteosarcoma and metastatic Ewing's sarcoma with lung metastases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Osteosarcoma

Drugs mentioned

• BIO-11006

Snippet

Sponsor: Nicklaus Children's Hospital f/k/a Miami Children's Hospital | Conditions: Osteosarcoma Metastatic, Ewing's Sarcoma Metastatic | Phase 2 | Status: WITHDRAWN